Sitryx Therapeutics Funding: $75M Raised, Series B

Sitryx Therapeutics is based in Oxford, Country not specified. It has raised $75M in total funding. Latest round: Series B.

Sitryx Therapeutics funding overview

Sitryx Therapeutics is based in Oxford, Country not specified. Sitryx Therapeutics has raised $75M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B. Investors on record include SV Health Investors, Sofinnova Partners, GSK, Longwood Fund, Oxford Science Enterprises, Eli Lilly & Company. 6 distinct backers are named across the disclosed rounds.

Sitryx Therapeutics at a glance

Total raised
$75M
Latest round
Series B
Headquarters
Oxford, Country not specified
Notable investors
SV Health Investors, Sofinnova Partners, GSK, Longwood Fund, Oxford Science Enterprises, Eli Lilly & Company

Frequently asked about Sitryx Therapeutics funding

How much has Sitryx Therapeutics raised?
Sitryx Therapeutics has raised $75M in total disclosed funding across the rounds on record.
Who has invested in Sitryx Therapeutics?
SV Health Investors, Sofinnova Partners, GSK, Longwood Fund, Oxford Science Enterprises, Eli Lilly & Company are named among the investors backing Sitryx Therapeutics.
What was the latest Sitryx Therapeutics funding round?
The most recent disclosed round is a Series B.
Where is Sitryx Therapeutics based?
Sitryx Therapeutics is based in Oxford, Country not specified.

Every Sitryx Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Oxford at a similar stage.

Companies related to Sitryx Therapeutics (36)

Browse related funding lists (6)

Company funding database · Investor directory · Founder database · Mega-rounds 2026